Top Key Companies for Needle-Free Drug Delivery Systems Market: Injex Pharma AG, Mystic Pharmaceuticals, Inc, Valeritas, Inc, Pharmajet, Inc, MedImmune, Inc, Zogenix, Inc, Antares Pharma, Inc., Optinose, Inc, 3M Pharmaceuticals, BD (, Crossject SA.
Global Needle-Free Drug Delivery Systems Market Research Report: 2023-2030 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Needle-Free Drug Delivery Systems Market Overview And Scope:
The Global Needle-Free Drug Delivery Systems Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Needle-Free Drug Delivery Systems utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Needle-Free Drug Delivery Systems Market Segmentation
By Type, Needle-Free Drug Delivery Systems market has been segmented into:
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
By Application, Needle-Free Drug Delivery Systems market has been segmented into:
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
Regional Analysis of Needle-Free Drug Delivery Systems Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Needle-Free Drug Delivery Systems Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Needle-Free Drug Delivery Systems market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Needle-Free Drug Delivery Systems market.
Top Key Companies Covered in Needle-Free Drug Delivery Systems market are:
Injex Pharma AG
Mystic Pharmaceuticals
Inc
Valeritas
Inc
Pharmajet
Inc
MedImmune
Inc
Zogenix
Inc
Antares Pharma
Inc.
Optinose
Inc
3M Pharmaceuticals
BD (
Crossject SA
Key Questions answered in the Needle-Free Drug Delivery Systems Market Report:
1. What is the expected Needle-Free Drug Delivery Systems Market size during the forecast period, 2022-2028?
2. Which region is the largest market for the Needle-Free Drug Delivery Systems Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Needle-Free Drug Delivery Systems Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Needle-Free Drug Delivery Systems Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Needle-Free Drug Delivery Systems companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Needle-Free Drug Delivery Systems Markets?
7. How is the funding and investment landscape in the Needle-Free Drug Delivery Systems Market?
8. Which are the leading consortiums and associations in the Needle-Free Drug Delivery Systems Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Needle-Free Drug Delivery Systems Market by Type
5.1 Needle-Free Drug Delivery Systems Market Overview Snapshot and Growth Engine
5.2 Needle-Free Drug Delivery Systems Market Overview
5.3 Jet-based Needle-free Injectors
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Jet-based Needle-free Injectors: Geographic Segmentation
5.4 Spring-based Needle-free Injectors
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Spring-based Needle-free Injectors: Geographic Segmentation
5.5 Laser-based Needle-free Injectors
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Laser-based Needle-free Injectors: Geographic Segmentation
Chapter 6: Needle-Free Drug Delivery Systems Market by Application
6.1 Needle-Free Drug Delivery Systems Market Overview Snapshot and Growth Engine
6.2 Needle-Free Drug Delivery Systems Market Overview
6.3 Insulin Needle-free Drug Delivery
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Insulin Needle-free Drug Delivery: Geographic Segmentation
6.4 Vaccine Needle-free Drug Delivery
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Vaccine Needle-free Drug Delivery: Geographic Segmentation
6.5 Pediatric Needle-free Drug Delivery
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Pediatric Needle-free Drug Delivery: Geographic Segmentation
6.6 Pain Needle-free Drug Delivery
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Pain Needle-free Drug Delivery: Geographic Segmentation
6.7 Other Needle-free Drug Delivery
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2016-2030F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Other Needle-free Drug Delivery: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Needle-Free Drug Delivery Systems Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Needle-Free Drug Delivery Systems Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Needle-Free Drug Delivery Systems Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 INJEX PHARMA AG
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MYSTIC PHARMACEUTICALS
7.4 INC
7.5 VALERITAS
7.6 INC
7.7 PHARMAJET
7.8 INC
7.9 MEDIMMUNE
7.10 INC
7.11 ZOGENIX
7.12 INC
7.13 ANTARES PHARMA
7.14 INC.
7.15 OPTINOSE
7.16 INC
7.17 3M PHARMACEUTICALS
7.18 BD (
7.19 CROSSJECT SA
Chapter 8: Global Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Jet-based Needle-free Injectors
8.2.2 Spring-based Needle-free Injectors
8.2.3 Laser-based Needle-free Injectors
8.3 Historic and Forecasted Market Size By Application
8.3.1 Insulin Needle-free Drug Delivery
8.3.2 Vaccine Needle-free Drug Delivery
8.3.3 Pediatric Needle-free Drug Delivery
8.3.4 Pain Needle-free Drug Delivery
8.3.5 Other Needle-free Drug Delivery
Chapter 9: North America Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Jet-based Needle-free Injectors
9.4.2 Spring-based Needle-free Injectors
9.4.3 Laser-based Needle-free Injectors
9.5 Historic and Forecasted Market Size By Application
9.5.1 Insulin Needle-free Drug Delivery
9.5.2 Vaccine Needle-free Drug Delivery
9.5.3 Pediatric Needle-free Drug Delivery
9.5.4 Pain Needle-free Drug Delivery
9.5.5 Other Needle-free Drug Delivery
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Jet-based Needle-free Injectors
10.4.2 Spring-based Needle-free Injectors
10.4.3 Laser-based Needle-free Injectors
10.5 Historic and Forecasted Market Size By Application
10.5.1 Insulin Needle-free Drug Delivery
10.5.2 Vaccine Needle-free Drug Delivery
10.5.3 Pediatric Needle-free Drug Delivery
10.5.4 Pain Needle-free Drug Delivery
10.5.5 Other Needle-free Drug Delivery
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Jet-based Needle-free Injectors
11.4.2 Spring-based Needle-free Injectors
11.4.3 Laser-based Needle-free Injectors
11.5 Historic and Forecasted Market Size By Application
11.5.1 Insulin Needle-free Drug Delivery
11.5.2 Vaccine Needle-free Drug Delivery
11.5.3 Pediatric Needle-free Drug Delivery
11.5.4 Pain Needle-free Drug Delivery
11.5.5 Other Needle-free Drug Delivery
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Jet-based Needle-free Injectors
12.4.2 Spring-based Needle-free Injectors
12.4.3 Laser-based Needle-free Injectors
12.5 Historic and Forecasted Market Size By Application
12.5.1 Insulin Needle-free Drug Delivery
12.5.2 Vaccine Needle-free Drug Delivery
12.5.3 Pediatric Needle-free Drug Delivery
12.5.4 Pain Needle-free Drug Delivery
12.5.5 Other Needle-free Drug Delivery
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Jet-based Needle-free Injectors
13.4.2 Spring-based Needle-free Injectors
13.4.3 Laser-based Needle-free Injectors
13.5 Historic and Forecasted Market Size By Application
13.5.1 Insulin Needle-free Drug Delivery
13.5.2 Vaccine Needle-free Drug Delivery
13.5.3 Pediatric Needle-free Drug Delivery
13.5.4 Pain Needle-free Drug Delivery
13.5.5 Other Needle-free Drug Delivery
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Needle-Free Drug Delivery Systems Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Jet-based Needle-free Injectors
14.4.2 Spring-based Needle-free Injectors
14.4.3 Laser-based Needle-free Injectors
14.5 Historic and Forecasted Market Size By Application
14.5.1 Insulin Needle-free Drug Delivery
14.5.2 Vaccine Needle-free Drug Delivery
14.5.3 Pediatric Needle-free Drug Delivery
14.5.4 Pain Needle-free Drug Delivery
14.5.5 Other Needle-free Drug Delivery
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Needle-Free Drug Delivery Systems Scope:
|
Report Data
|
Needle-Free Drug Delivery Systems Market
|
|
Needle-Free Drug Delivery Systems Market Size in 2022
|
USD XXX million
|
|
Needle-Free Drug Delivery Systems CAGR 2023 - 2030
|
XX%
|
|
Needle-Free Drug Delivery Systems Base Year
|
2022
|
|
Needle-Free Drug Delivery Systems Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Injex Pharma AG, Mystic Pharmaceuticals, Inc, Valeritas, Inc, Pharmajet, Inc, MedImmune, Inc, Zogenix, Inc, Antares Pharma, Inc., Optinose, Inc, 3M Pharmaceuticals, BD (, Crossject SA.
|
|
Key Segments
|
By Type
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
By Applications
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
|
